CD274 and cancer: In addition, KEGG pathways analysis suggests that this network is enriched in pathways including the JAK-STAT signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, and EGFR tyrosine kinase inhibitor resistance (Figure 9(a)).